Skip to main content
. 2021 Apr 30;12:672519. doi: 10.3389/fimmu.2021.672519

Figure 1.

Figure 1

The mitogenic and metabolic pathways of insulin signaling. AKT/PKB, protein-kinase B; AS160, AKT substrate of 160kDa; Bcl-2, B-cell lymphoma 2; ERK, extracellular signal-regulated kinases; FoxO, forkhead box-containing protein O subfamily; GRB2, growth factor receptor-bound protein 2; GSK3, glycogen synthase kinase 3; IRS, insulin receptor substrate; MEK, MAPK/ERK Kinase; mTOR, mammalian target of rapamycin; PDK1/PDK2, phosphoinositide-dependent protein kinase; PI3K, phosphoinositide-3 kinase; PIP2, phosphatidylinositol (4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; RAF, rapidly accelerated fibrosarcoma; RAS, Rouss avian sarcoma; Shc, Src-homology collagen; SOS, son of sevenless. Figure 1 has been created using BioRender (www.biorender.com).